secwatch / observer
8-K filed March 14, 2025, 7:59 PM ET ticker MTNB CIK 0001582554
leadership confidence high sentiment neutral materiality 0.40

Matinas BioPharma Chairman Eric Ende resigns from Board effective March 14

Matinas BioPharma Holdings, Inc.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Eric Ende

Chairman of the Board
MTNB · Matinas BioPharma Holdings, Inc.
Effective
2025-03-14
Filed
March 14, 2025, 7:59 PM ET
On March 13, 2025, Eric Ende informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning as a member of the Board and as Chairman of the Board effective March 14, 2025, due to his other professional obligations.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Eric Ende resigned as Chairman of the Board at Matinas BioPharma Holdings, Inc..

Action
resigned
Role
Chairman of the Board
Exact text from the filing
On March 13, 2025, Eric Ende informed the Board of Directors (the “ Board ”) of Matinas BioPharma Holdings, Inc. (the “ Company ”) that he was resigning as a member of the Board and as Chairman of the Board effective March 14, 2025, due to his other professional obligations.
View on SEC.gov

Matinas BioPharma Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-25-010416
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.